Trial intelligence / Profile preview

Platelet-rich plasma vs steroid injection for lumbar facet joint arthritis

TCTR20210401005Phase 3Not yet recruiting

Sponsor
Ratchadaphiseksomphot Endowment Fund
Start
May 2021
Countries
1
01

Overview

A Phase 3 trial of platelet-rich plasma in Facet Joint Disorder, sponsored by Ratchadaphiseksomphot Endowment Fund. Planned start May 2021; status: not yet recruiting.

02

Drugs

platelet-rich plasma
03

Conditions

Facet Joint Disorder

Beyond the preview

Go deeper on TCTR20210401005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210401005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call